H-coil repetitive transcranial magnetic stimulation for pain relief in patients with diabetic neuropathy. To read the original source, use Pubmed and search for Title of the citation Eur J Pain. Magnetic Therapy Neuropathy – Pulsed Electromagnetic Field Therapy PEMF Bibliography
#Neuronyx garnet plus#
We guarantee satisfaction in 90-days or return for refund no matter why you buy your EarthPulse™ plus better sleep and overall improved quality of life. See also our bibliography on Magnetic Therapy and General Pain with many more studies on pain than simply those termed neuropathy / neuropathic.
Another area where there is no funding for research since BigPharma counts on sales of pain meds so heavily. It doesn’t just treat the pain, it repairs the cause of the pain. Beside promoting various physiological, psychological and neurological healing mechanisms, PEMF’s turn on body’s ability to regenerate bone, muscle and nerve tissue and reduce inflammation. In a further embodiment, a substantially homogenous populaton of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.Pulsed Magnetic Therapy for Neuropathy using Pulsed Electromagnetic Field therapies PEMF have been found to have beneficial and protective neurological effects. The committed progenitor cells can be employed to treat a human suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition and to formulate pharmaceutical compositions. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell populations which co-express CD49c and CD90 and modifying the cell population. In one embodiment, humans suffering from a degenerative, traumatic, acute injury, cardiac or neurological condition are treated with the substantially homogenous cells populations which co-express CD49c, CD90 and telomerase.
In a further embodiment, a substantially homogenous population of cells which co-express CD49c, CD90 and at least one cardiac-related transcription factor is made and can be used to treat a human suffering from a cardiac condition.Ībstract: Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. In another embodiment, committed progenitor cells are made are made by selecting from a cultured source of a cell population which co-express CD49c and CD90 and modifying the cell population.
Publication/Patent Number: US20070224177A1Ībstract: Substantially homogenous cells populations which co-express CD49c, CD90 and telomerase are made. For example, adult bone marrow-derived somatic cells (ABM-SC), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries. Publication/Patent Number: WO2008156728A1Ībstract: The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self- renewing, colony forming somatic cells (CF-SC).
0 kommentar(er)
